FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400869884> ?p ?o ?g. }

• W2400869884 endingPage "268" @default.
• W2400869884 startingPage "257" @default.
• W2400869884 abstract "Angiotensin converting enzyme inhibitors (ACEi) are the current standard of care treatment for cardiac dysfunction in Duchenne muscular dystrophy patients. We previously showed treatment with an ACEi plus mineralocorticoid receptor (MR) antagonist improves limb and respiratory skeletal muscles, in addition to cardiac muscles, in a dystrophic mouse model at 20 weeks-of-age.To determine whether previously observed preclinical benefits of an ACEi plus MR antagonist on dystrophic skeletal muscles can be reproduced by increasing ACEi dosage alone. We also compared functional and histological outcome measures at 10 and 20 weeks-of-age.Dystrophin deficient utrophin haplo-insufficient (utrn+/-; mdx) het mice were treated with 10, 20, or 50 mg/kg × day of the ACEi lisinopril from 4 to 10 weeks-of-age via water bottles and compared with C57BL/10 wild-type control mice and untreated hets. Data from 10 week-old het mice were also compared to data collected from an untreated het group at 20 weeks-old. In vivo cardiac and grip strength measurements, in vitro diaphragm and extensor digitorum longus muscle force measurements, and histopathological analyses were performed. One-way ANOVA followed by Dunnett post hoc comparison was used to determine significance.ACEi treatment reduced skeletal muscle damage but had no significant effect on muscle force. Body weight, heart rate, grip strength and blood pressure were unaffected by treatment. Limb muscle histopathology was more informative at 10 than 20 weeks-of-age.These results suggest increased ACEi dosage alone cannot improve all dystrophic parameters. Further optimization of MR antagonists in 20 week-old mice is warranted." @default.
• W2400869884 created "2016-06-24" @default.
• W2400869884 creator A5006770008 @default.
• W2400869884 creator A5008439616 @default.
• W2400869884 creator A5010539623 @default.
• W2400869884 creator A5025821438 @default.
• W2400869884 creator A5035192310 @default.
• W2400869884 creator A5037038264 @default.
• W2400869884 creator A5048166351 @default.
• W2400869884 creator A5053324672 @default.
• W2400869884 creator A5074021476 @default.
• W2400869884 creator A5076651343 @default.
• W2400869884 creator A5090931617 @default.
• W2400869884 date "2015-09-02" @default.
• W2400869884 modified "2023-09-27" @default.
• W2400869884 title "The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy" @default.
• W2400869884 cites W1602001829 @default.
• W2400869884 cites W1981102501 @default.
• W2400869884 cites W2016718174 @default.
• W2400869884 cites W2019563312 @default.
• W2400869884 cites W2041938024 @default.
• W2400869884 cites W2042809566 @default.
• W2400869884 cites W2046533346 @default.
• W2400869884 cites W2050860068 @default.
• W2400869884 cites W2056405635 @default.
• W2400869884 cites W2057826343 @default.
• W2400869884 cites W2067635871 @default.
• W2400869884 cites W2074829477 @default.
• W2400869884 cites W2080434175 @default.
• W2400869884 cites W2083119896 @default.
• W2400869884 cites W2102086668 @default.
• W2400869884 cites W2140357699 @default.
• W2400869884 cites W2152156772 @default.
• W2400869884 cites W2154041187 @default.
• W2400869884 doi "https://doi.org/10.3233/jnd-150099" @default.
• W2400869884 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4838202" @default.
• W2400869884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27110493" @default.
• W2400869884 hasPublicationYear "2015" @default.
• W2400869884 type Work @default.
• W2400869884 sameAs 2400869884 @default.
• W2400869884 citedByCount "17" @default.
• W2400869884 countsByYear W24008698842015 @default.
• W2400869884 countsByYear W24008698842016 @default.
• W2400869884 countsByYear W24008698842017 @default.
• W2400869884 countsByYear W24008698842018 @default.
• W2400869884 countsByYear W24008698842019 @default.
• W2400869884 countsByYear W24008698842020 @default.
• W2400869884 countsByYear W24008698842021 @default.
• W2400869884 countsByYear W24008698842022 @default.
• W2400869884 crossrefType "journal-article" @default.
• W2400869884 hasAuthorship W2400869884A5006770008 @default.
• W2400869884 hasAuthorship W2400869884A5008439616 @default.
• W2400869884 hasAuthorship W2400869884A5010539623 @default.
• W2400869884 hasAuthorship W2400869884A5025821438 @default.
• W2400869884 hasAuthorship W2400869884A5035192310 @default.
• W2400869884 hasAuthorship W2400869884A5037038264 @default.
• W2400869884 hasAuthorship W2400869884A5048166351 @default.
• W2400869884 hasAuthorship W2400869884A5053324672 @default.
• W2400869884 hasAuthorship W2400869884A5074021476 @default.
• W2400869884 hasAuthorship W2400869884A5076651343 @default.
• W2400869884 hasAuthorship W2400869884A5090931617 @default.
• W2400869884 hasBestOaLocation W24008698841 @default.
• W2400869884 hasConcept C111566952 @default.
• W2400869884 hasConcept C126322002 @default.
• W2400869884 hasConcept C134018914 @default.
• W2400869884 hasConcept C142724271 @default.
• W2400869884 hasConcept C167414201 @default.
• W2400869884 hasConcept C27016395 @default.
• W2400869884 hasConcept C2777880890 @default.
• W2400869884 hasConcept C2778198053 @default.
• W2400869884 hasConcept C2778943923 @default.
• W2400869884 hasConcept C2779030066 @default.
• W2400869884 hasConcept C2779134260 @default.
• W2400869884 hasConcept C2779611605 @default.
• W2400869884 hasConcept C2779959927 @default.
• W2400869884 hasConcept C2779969927 @default.
• W2400869884 hasConcept C2780394045 @default.
• W2400869884 hasConcept C544855455 @default.
• W2400869884 hasConcept C71924100 @default.
• W2400869884 hasConcept C84393581 @default.
• W2400869884 hasConceptScore W2400869884C111566952 @default.
• W2400869884 hasConceptScore W2400869884C126322002 @default.
• W2400869884 hasConceptScore W2400869884C134018914 @default.
• W2400869884 hasConceptScore W2400869884C142724271 @default.
• W2400869884 hasConceptScore W2400869884C167414201 @default.
• W2400869884 hasConceptScore W2400869884C27016395 @default.
• W2400869884 hasConceptScore W2400869884C2777880890 @default.
• W2400869884 hasConceptScore W2400869884C2778198053 @default.
• W2400869884 hasConceptScore W2400869884C2778943923 @default.
• W2400869884 hasConceptScore W2400869884C2779030066 @default.
• W2400869884 hasConceptScore W2400869884C2779134260 @default.
• W2400869884 hasConceptScore W2400869884C2779611605 @default.
• W2400869884 hasConceptScore W2400869884C2779959927 @default.
• W2400869884 hasConceptScore W2400869884C2779969927 @default.
• W2400869884 hasConceptScore W2400869884C2780394045 @default.
• W2400869884 hasConceptScore W2400869884C544855455 @default.
• W2400869884 hasConceptScore W2400869884C71924100 @default.
• W2400869884 hasConceptScore W2400869884C84393581 @default.

• next